According to a study published on JAMA Network, teenagers who use e-cigarettes are more likely to try marijuana a year later compared to those who do not use e-cigarettes. However, the researchers warned that while there is a strong correlation at the individual level, the association between e-cigarette use and teenage marijuana use at the population level appears to be small. Previous studies have examined the association between teenage e-cigarette use and marijuana use, but given the increasing popularity of e-cigarettes, researchers hope to obtain more recent data.
They analyzed longitudinal data from the 4.5 (2017-2018) and 5 (2018-2019) waves of the Population Assessment of Tobacco and Health (PATH) study. They specifically compared teenagers who used e-cigarettes in the past 12 months or past 30 days to those who used marijuana in the same time frames. The study involved data from 9,828 adolescents.
Image source: Getty Images
Today on the Haymarket Healthcare Network, it was reported that low-dose fluoxetine can reduce the use of diazepam during benzodiazepine detox, and is associated with improved psychological resilience and walking ability following hip fracture. Additionally, Pimavanserin has been linked to lower mortality rates among some Parkinson's disease patients. Adolescents who have used e-cigarettes at some point have a 13.93% higher risk of using marijuana one year later than those who have never used e-cigarettes. Individuals who have used e-cigarettes in the past year have a 14.89% higher risk. Those who have used e-cigarettes in the past 30 days have an 11.86% increased risk of using marijuana.
Researchers suggest that e-cigarette users are more likely to engage in risky behavior or may have friends who use marijuana. The fact that e-cigarettes can be used to consume marijuana may also be a contributing factor. However, the researchers report that population-level marijuana use has remained relatively stable from 1995 to 2020. The small sample size of the current study may be to blame: only 7.8% of surveyed non-marijuana using adolescents had ever used e-cigarettes. The researchers state that, according to the data, "the estimated change in population-level marijuana use due to e-cigarette use is less than 1 percentage point.
The study did not control for state-level legalization of marijuana among its limitations. Additionally, the use of self-reported data may have skewed the research results. Overall, the researchers concluded that "the use of e-cigarettes appears to have little correlation with overall prevalence of adolescent marijuana use" and that "adolescent marijuana use has remained relatively stable over the past quarter-century at the population level.
Statement
This article is compiled from third-party information and is provided for the purpose of industry communication and learning.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is only intended for industry communication and research purposes.
Due to limitations in translation ability, the translated article may not accurately reflect the original text. Please refer to the original article for accuracy.
2FIRSTS maintains full alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
